Japan Could Miss Out on Wave 1 of Drug Development, Re-Do and Do Right on PMP: PhRMA

PhRMA Japan Executive Committee Chairman Patrik Jonsson With the planned scale-down of the so-called price maintenance premium (PMP) to be carried out in April, Japan might not be able to maintain its position to be in the first wave of...read more